Grace Breeding Ltd (TASE: GRAC)
Health Care · Biotechnology · IL
₪17.06
— today · -23.3% 1Y
Grace Breeding Ltd (TASE: GRAC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $23.40M and employs 2 people.
Over the last twelve months the share price has lost 23.3%, trading between 11.06 and 23.00.
Tweenvest scores Grace Breeding Ltd across four factors: quality 22/100. Its strongest factor is quality.
GRAC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.40M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.54
- Dividend yield
- —
- Beta (5Y)
- 0.38
- 52-week high
- ₪23.00
- 52-week low
- ₪11.06
- Avg volume (3M)
- —
- Shares outstanding
- 4.18M
- Employees
- 2
- Next earnings
- —
About Grace Breeding Ltd
Grace Breeding Ltd, an agro-tech company, engages in the research and development in the area of biological substitutes for synthetic materials used in the fertilizer and growth promoter industries in Israel and internationally. The company also sells seeds. Its product portfolio includes Maoz, a biofertilizer that aids with photosynthesis; ProMagen, a combination of plant materials with anti-inflammatory properties for biotic stress tolerance; and ClimAid for abiotic stress tolerance. Grace Breeding Ltd was incorporated in 2015 and is based in Ramat Gan, Israel.
- ISIN
- IL0011843658
- Founded
- 2015
- Listed since
- Feb 13, 2022
- Exchange
- The Tel-Aviv Stock Exchange
- Currency
- ILS
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.82 | +0.39% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $445.50 | +0.74% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.06 | -0.48% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.